<DOC>
	<DOCNO>NCT00816205</DOCNO>
	<brief_summary>This open label , dose-finding study . Approximately 8 healthy subject participate study . Within one week screen visit , subject meet inclusion criterion none exclusion criterion enter one day treatment period . During period , 4 anal manometric study take place . Study medication ( Coated Nifedipine suppositories various dos ) administer pre-determined interval . During study , blood sample obtain plasma Nifedipine analysis .</brief_summary>
	<brief_title>An Open Label Study Examine Effect Coated Nifedipine Suppositories Anal Pressure Healthy Subjects</brief_title>
	<detailed_description>After detrminig baseline rest anal pressure manometric test , coat Suppositories administer intra rectally . Subjects take rectally total 3 Coated Suppositories per study . 90 minute coat suppository insertion suppository remove amnometric study perform : The first dose contain 4 mg Nifedipine manomentric measurement perform afterwards use determine baseline anal pressure . The second dose contain 12 mg Nifedipine . The third dose contain 24 mg Nifedipine . The primary efficacy parameter change Resting Anal Pressure baseline . The secondary efficacy parameter include follow : - The ratio change anal pressure plasma Nifedipine level . - The ratio change anal pressure change blood pressure . - The ratio change anal pressure change heart rate .</detailed_description>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>Subjects meet follow criterion eligible participate trial : Signed write informed consent ; Male female subject 18 55 year age ; Subjects exclude participation study follow criterion apply : Has clinically significant history presence follow condition : Known allergy Nifedipine , polyethyleneglycol , Propyleneglycol silicone . Active past history disease require medication clinical follow . Malignant disease within 5 year screen ; History ano rectal disease . History gastrointestinal disease . History gastrointestinal bleeding . History rectal surgery . History gastrointestinal surgery . History HIV . In need chronic use medication , exception birth control medication . Currently use medication acute illness . Has upon physical examination rectal deformation sign rectal disease fissure , bleed hemorrhoid , fistula. , infection space occupy lesion . Has receive investigational drug within 90 day screen ; Receipt investigational treatment ( drug device ) within 90 day prior screen ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>